On July 15, Cardiac Medical announced that the Aorfix™ abdominal aortic laminating stent system, a product in the field of interventional treatment of abdominal aortic diseases developed by its European subsidiary Lombard Medical Co., Ltd., was officially approved to enter the China Drug Administration's special review process for innovative medical devices.

Zhitongcaijing · 1d ago
On July 15, Cardiac Medical announced that the Aorfix™ abdominal aortic laminating stent system, a product in the field of interventional treatment of abdominal aortic diseases developed by its European subsidiary Lombard Medical Co., Ltd., was officially approved to enter the China Drug Administration's special review process for innovative medical devices.